A CD2/CD28 chimeric receptor triggers the CD28 signaling pathway in CTLL.2 cells
β Scribed by Feldhaus, A L; Evans, L; Sutherland, R A; Jones, L A
- Book ID
- 110038040
- Publisher
- Nature Publishing Group
- Year
- 1997
- Tongue
- English
- Weight
- 323 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0969-7128
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Signaling via CD28 costimulates lymphokine production, but does not reverse unresponsiveness to interleukin-2 in anti-CD3 triggered T h l cells* Mikrobiologie, Universitat Erlangen-Nurnberg, Erlangen Previously, it has been described that the ability of murineTh1 cells to proliferate in respons
## Abstract Adenosine is an immunosuppressive molecule that is associated with the microenvironment of solid tumors. Mouse T cells activated with antiβCD3 antibody in the presence of adenosine with or without coformycin (to prevent adenosine breakdown by adenosine deaminase) exhibited decreased tyr
## Abstract The therapeutic success of adoptive therapy with chimeric antigen receptor (CAR) engineered T cells depends on the appropriate costimulation of CD3ΞΆ to induce full T cell activation. Costimulatory endodomains of the CD28 family are therefore fused with CD3ΞΆ in a dual signalling CAR. Ser